• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and nursing is challenging for women with the condition. Little data exists about how long-term exposure to these medications can affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental disorders like hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the benefits of using them against the risks to the foetus. Physicians don't have the data to give clear advice but they can provide information about risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at a greater risk of fetal malformations, or structural birth defects. The researchers used a large, population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was accurate and to minimize any bias.

However, the study was not without its flaws. In particular, they were not able to differentiate the effects of the medication from the effects of the disorder at hand. That limitation makes it difficult to know whether the small associations observed in the groups that were exposed result from medication use or confounding by comorbidities. Additionally, the researchers did not examine the long-term effects of offspring on their parents.

The study did find that infants whose mothers had taken ADHD medications during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk for admission did not appear to be affected by the type of stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medication during pregnancies in the early stages can be offset by greater benefits to both baby and mother of continued treatment for the woman's condition. Physicians should talk to their patients about this issue and as much as possible, assist them improve coping skills which can lessen the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, doctors have to take into account their own experience and experience, as well as the experiences of other doctors and the research on the topic.

The issue of risk to the infant can be extremely difficult. A lot of studies on this issue are based on observational data instead of controlled research and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which could undervalue the serious teratogenic effects that can result in abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion: While certain studies have demonstrated an association between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link and the majority of studies have a neutral or slight negative effect. In the end an accurate risk-benefit analysis must be done in each case.

It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation, and family conflict for these patients. In addition, a decrease in medication can interfere with the ability to complete work-related tasks and safely drive which are essential aspects of a normal life for many people with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy should educate family members, coworkers and acquaintances about the condition, the impact on daily functioning and the advantages of staying on the current treatment plan. In addition, educating them can aid in ensuring that the woman feels supported in her struggle with her decision. Certain medications can pass through the placenta. If a woman decides not to take her ADHD medication while breastfeeding, it is important to be aware that the medication could be transferred to the baby.

Risk of Birth Defects

As the use and misuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so does concern about the potential adverse effects of the drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing information on this topic. Researchers used two huge data sets to study more than 4.3 million pregnancy and determine if the use of stimulant medications caused birth defects. Researchers discovered that, while the overall risk is low, first-trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, such as ventriculoseptal defect.

The authors of the study could not discover any connection between early use of medication and other congenital anomalies like facial deformities or club feet. The results are in line with previous studies that have shown the presence of a small, but significant increase in the risk of heart malformations in women who started taking ADHD medications prior to the time of pregnancy. The risk grew in the latter half of pregnancy, when a lot of women are forced to stop taking their adhd medication online uk medications.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean birth, have a low Apgar after delivery and have a baby that needed help breathing when they were born. However the authors of the study were unable to eliminate bias due to selection by limiting the study to women who didn't have any other medical issues that could have contributed to these findings.

Researchers hope that their study will help doctors when they see pregnant women. They advise that while a discussion of risks and benefits is important but the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it is not a recommended practice because of the high incidence of depression and other mental health problems in women who are pregnant or postpartum. Further, the research suggests that women who decide to stop taking their medications are more likely to have a difficult time getting used to life without them following the birth of their baby.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women suffering from ADHD can face severe challenges when they must manage their symptoms, attend doctor appointments, prepare for the birth of a baby and adjust to new routines. As such, many women choose to continue taking their starting adhd medication adults medication throughout the pregnancy.

The majority of stimulant medications are absorbed by breast milk in very small amounts, so the risk to nursing infant is very low. The rate of exposure to medication can vary depending upon the dosage, frequency of administration and time of day. In addition, different types of adhd medication drugs enter the infant's system through the gastrointestinal tract or through breast milk. The effect on the health of a newborn isn't fully comprehended.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the absence of research. This is a difficult decision for the woman, who must weigh the advantages of taking her medication as well as the potential risks to the embryo. In the meantime, until more information is available, GPs can inquire about pregnant patients if they have any background of ADHD or if they plan to take medication in the perinatal stage.

Numerous studies have demonstrated that women can continue to take their adhd medication weight loss uk medication without risk during pregnancy and while breast-feeding. In response, a growing number of patients are choosing to do this. They have discovered through consultation with their doctor that the benefits of retaining their current medication outweigh risk.

It's important for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons for continuing treatment. This includes Non stimulant adhd medications for Adults-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from ADHD understand the symptoms and underlying disorder. They should also be informed about treatment options and build strategies for coping. This should be a multidisciplinary process together with obstetricians, GPs, and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, as well as monitoring for signs of deterioration and, if needed, adjustments to the medication regime.